These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35346372)

  • 21. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
    Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
    Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.
    Zhao C; Ling X; Xia Y; Yan B; Guan Q
    Cancer Cell Int; 2021 Aug; 21(1):441. PubMed ID: 34419065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia-inducible lncRNA MIR210HG interacting with OCT1 is involved in glioblastoma multiforme malignancy.
    Ho KH; Shih CM; Liu AJ; Chen KC
    Cancer Sci; 2022 Feb; 113(2):540-552. PubMed ID: 34897892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N6-methyladenosine (m6A)-mediated up-regulation of long noncoding RNA LINC01320 promotes the proliferation, migration, and invasion of gastric cancer via miR495-5p/RAB19 axis.
    Hu N; Ji H
    Bioengineered; 2021 Dec; 12(1):4081-4091. PubMed ID: 34288797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. METTL3-mediated m6A modification of KIF3C-mRNA promotes prostate cancer progression and is negatively regulated by miR-320d.
    Ma H; Zhang F; Zhong Q; Hou J
    Aging (Albany NY); 2021 Sep; 13(18):22332-22344. PubMed ID: 34537760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IGF2BP1-mediated N6-methyladenosine modification promotes intrahepatic cholangiocarcinoma progression.
    Xiao P; Meng Q; Liu Q; Lang Q; Yin Z; Li G; Li Z; Xu Y; Yu Z; Geng Q; Zhang Y; Liu L; Xie Y; Li L; Chen H; Pei T; Sun B
    Cancer Lett; 2023 Mar; 557():216075. PubMed ID: 36736530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA expression profiling identifies MIR210HG as a novel molecule in severe preeclampsia.
    Lei D; Fang C; Deng N; Yao B; Fan C
    Life Sci; 2021 Apr; 270():119121. PubMed ID: 33516697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma.
    Zhou X; Zhang CZ; Lu SX; Chen GG; Li LZ; Liu LL; Yi C; Fu J; Hu W; Wen JM; Yun JP
    Oncogene; 2015 Feb; 34(8):965-77. PubMed ID: 24632613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factor 2 mRNA-binding protein 1 promotes cell proliferation
    Wan BS; Cheng M; Zhang L
    World J Gastroenterol; 2019 Oct; 25(40):6063-6076. PubMed ID: 31686763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppressive role of microRNA-29 in hepatocellular carcinoma via targeting IGF2BP1.
    Yang J; Gong X; Yang J; Ouyang L; Xiao R; You X; Ouyang Y
    Int J Clin Exp Pathol; 2018; 11(3):1175-1185. PubMed ID: 31938212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IGF2BP1 harbors prognostic significance by gene gain and diverse expression in neuroblastoma.
    Bell JL; Turlapati R; Liu T; Schulte JH; Hüttelmaier S
    J Clin Oncol; 2015 Apr; 33(11):1285-93. PubMed ID: 25753434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MIR210HG predicts poor prognosis and functions as an oncogenic lncRNA in hepatocellular carcinoma.
    Wang Y; Li W; Chen X; Li Y; Wen P; Xu F
    Biomed Pharmacother; 2019 Mar; 111():1297-1301. PubMed ID: 30841443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA MIR210HG promotes proliferation and invasion of non-small cell lung cancer by upregulating methylation of CACNA2D2 promoter via binding to DNMT1.
    Kang X; Kong F; Huang K; Li L; Li Z; Wang X; Zhang W; Wu X
    Onco Targets Ther; 2019; 12():3779-3790. PubMed ID: 31190878
    [No Abstract]   [Full Text] [Related]  

  • 34. LncRNA THOR promotes tongue squamous cell carcinomas by stabilizing IGF2BP1 downstream targets.
    Yang H; Fu G; Liu F; Hu C; Lin J; Tan Z; Fu Y; Ji F; Cao M
    Biochimie; 2019 Oct; 165():9-18. PubMed ID: 31220513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis and validation of m6A regulatory network: a novel circBACH2/has-miR-944/HNRNPC axis in breast cancer progression.
    Lv W; Tan Y; Xiong M; Zhao C; Wang Y; Wu M; Wu Y; Zhang Q
    J Transl Med; 2021 Dec; 19(1):527. PubMed ID: 34952600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma.
    Zhao Y; Yan X; Wang Y; Zhou J; Yu Y
    Front Oncol; 2021; 11():726018. PubMed ID: 35299934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel MYCN-YTHDF1 cascade contributes to retinoblastoma tumor growth by eliciting m
    Luo Y; He M; Yang J; Zhang F; Chen J; Wen X; Fan J; Fan X; Chai P; Jia R
    Sci China Life Sci; 2023 Sep; 66(9):2138-2151. PubMed ID: 36949231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
    Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
    J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long Noncoding RNA
    Tang L; Chen Y; Tang X; Wei D; Xu X; Yan F
    J Cancer; 2020; 11(2):311-323. PubMed ID: 31897227
    [No Abstract]   [Full Text] [Related]  

  • 40. The m
    Zhong S; Lin Z; Chen H; Mao L; Feng J; Zhou S
    PeerJ; 2021; 9():e11561. PubMed ID: 34141492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.